Chengdu Huachuang Biotechnology Co., Ltd., established on 2012-02-10, The business scope includes biomedical research and development and providing technical consultation,technology transfer;Medical Research and Experimental Development;(The above-mentioned business projects are subject to approval according to law,Business activities can only be carried out after approval by relevant departments).

MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse. Antibiotics are the most prescribed class of drugs worldwide with a global market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system. ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases.

SL BIGEN is a research and development business that aims to save patients' lives through bio-genetic engineering. SL BIGEN is working on two projects: I a first-in-class mesenchymal stem cell line engineered to express disease-specific therapeutic genes, and (ii) a multi-engineered natural killer cell line expressing fourth generation chimeric antigen receptors. Cancer and neurological illnesses are among the therapeutic areas covered by the company.

Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digestion, skin scars, general cold, gum treatment, high blood pressure, infection, gastrointestinal tract control, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

Beike is the stem cell provider focusing on the research, development, and clinical translation of adult stem cells. they have also developed a range of immunotherapy treatments targeting a range of conditions. their goal is to not only provide high quality treatments to patients worldwide, but also to foster collaborations within the field of regenerative medicine by working with governments and clinicians worldwide to provide efficacious stem cell treatments.

Nanjing Huachuang Biotechnology Co., Ltd., established on 2021-03-08, Business scope includes licensed projects:pharmaceutical production;Disinfection equipment sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Manufacturing of bio-based materials;Experimental analysis instrument sales;Sales of Class I Medical Devices;Sales of daily chemical products;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.Founded in 2009 by Prof. Massimo Dominici and Prof. Pierfranco Conte, as a spin-off resulting from a joint venture between biomedical company RanD and researchers from the University of Modena and Reggio Emilia, Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative biocompatible materials.

Jiangsu Xiansheng Pharmaceutical Research Co., Ltd., established on 2004-02-10, Business scope includes licensed business items:No general operating items:medical products,Research on medical diagnostic reagents,Technology transfer and related technical consulting services.Self-operated and agent import and export business of various commodities and technologies.*

Beijing Beilai Biotechnology Co., Ltd., established on 2015-10-26, Business scope includes biotechnology development,technology transfer,technical consulting,Technical Services;Sales of daily necessities,cosmetic,Ι class medical device,Chemical Products,chemical reagent,plastic products,Glass product.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Shandong Xiansheng Biopharmaceutical Co., Ltd., established on 1999-06-30, Business scope includes research and development,to develop,Production,Sales of bioengineering products and related products,Dedicated transport of goods(Refrigerated),Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Wenlun Technology Co., Ltd., established on 2008-09-24, Business scope includes technology promotion;Business Management Consulting;Economic and Trade Consulting;Conference Services;design,make,acting,Place an ad;Undertake exhibition and display activities;Organize cultural and artistic exchange activities;sell electronics,Wujinjiaodian,building materials(Not engaged in physical store operation),metallic material,computer,Software and Auxiliary Equipment.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Part of AiDa Pharmaceuticals, Inc., Shanghai Qiaer Bio-Technology Co. Ltd. is a Chinese company located in Shanghai that manufactures pharmaceutical drugs; operates pharmaceutical-testing laboratories. It was acquired by AiDa Pharmaceuticals, Inc. from Zhejiang Medicine Co., Ltd. on August 14, 2006 for $0.50 million.

Shanghai Gebaide Biotechnology Co., Ltd., established on 2011-05-12, Business scope includes biomedical,Technical services in the field of biochemical medicine,technical consulting,technology development,technology transfer,drug development(not engaged in production,Sales),laboratory reagent(In addition to dangerous goods),laboratory consumables,Pharmaceutical Intermediates(In addition to drugs),Chemical raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Immunex Corporation develops, manufactures, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington. As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc.

Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan.